No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
No tracked top-trader positions in SKIN as of Oct 21, 19:23 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.04 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.02 / -$0.04Alpha Vantage | +$0.02 beat | $72.1M No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.03 / -$0.01Alpha Vantage | +$0.04 beat | $64.9M No estimate | Unavailable |
| Dec 31, 2025 | Mar 12, 2026 | -$0.06 / -$0.04Alpha Vantage | -$0.02 miss | $82.4M No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.57 / -$1.00Yahoo Finance | +$1.57 beat | $70.7M No estimate | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.03 / -$0.06Alpha Vantage | +$0.09 beat | $78.2M No estimate | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.04 / -$0.07Alpha Vantage | +$0.11 beat | $69.6M No estimate | Unavailable |
| Dec 31, 2024 | Mar 12, 2025 | -$0.08 / -$0.10Alpha Vantage | +20.00% beat | $83.5M No estimate | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | $0.04 / -$0.04Alpha Vantage | +$0.08 beat | $78.8M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $70.7M | $82.4M | $64.9M | $72.1M |
| Cost of what it sold | $25.0M | $29.3M | $20.5M | $22.8M |
| Gross profit | $45.6M | $53.0M | $44.4M | $49.3M |
| What it spent | ||||
| Research and development | $1.7M | $1.7M | $1.1M | $1.4M |
| Sales and admin | $29.3M | $27.7M | $21.9M | $23.3M |
| Other operating costs | $20.9M | $23.5M | $23.2M | $21.0M |
| Total operating expenses | $51.9M | $52.9M | $46.2M | $45.8M |
| What was left | ||||
| Operating profit | -$6.2M | $162.0K | -$1.8M | $3.6M |
| Interest on debt | $6.3M | $6.4M | $6.3M | $6.3M |
| Profit before tax | -$10.6M | -$4.8M | -$6.8M | -$1.5M |
| Tax | $386.0K | $3.3M | -$200.0K | $1.2M |
| Net profit | -$11.0M | -$8.1M | -$6.6M | -$2.7M |
| EBITDA | $4.1M | $6.9M | $4.9M | $10.1M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace